Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency

Cellular sumoylation processes are proposed targets for anti-viral and anti-cancer therapies. We reported that Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) dysregulates cellular sumoylation processes, contributing to its oncogenic potential in EBV-associated malignancies. Ginkgolic acid...

Descripción completa

Detalles Bibliográficos
Autores principales: Bentz, Gretchen L., Lowrey, Angela J., Horne, Dustin C., Nguyen, Vy, Satterfield, Austin R., Ross, Tabithia D., Harrod, Abigail E., Uchakina, Olga N., McKallip, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534330/
https://www.ncbi.nlm.nih.gov/pubmed/31125383
http://dx.doi.org/10.1371/journal.pone.0217578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534330/
https://www.ncbi.nlm.nih.gov/pubmed/31125383
http://dx.doi.org/10.1371/journal.pone.0217578

Ejemplares similares